Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

As the cell therapy industry continues to grow, it must face the challenge of creating products that are not only safe and effective, but also affordable. Currently, the prices for approved products ...

Achieving the manufacturing throughput necessary to satisfy expected patient demand is dependent on several factors, including decreasing reliance on large, expensive manufacturing facilities; ...

Challenges include the optimization of vector design, the control of bioreactor conditions, and the end-to-end integration of workflows However, cell therapies, defined as those where a patient is ...

SAN FRANCISCO--(BUSINESS WIRE)--Through integration with Multiply Labs' robotic technology, Thermo Fisher Scientific’s advanced, industry-leading cell therapy instruments, including the Thermo ...